Breaks Categories: News

TuesdayFeb 15, 2022 12:37 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names BayMedica VP of Sales, Releases Q2 2022 Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has appointed Gerard (Jerry) P. Griffin III as vice president of sales and marketing at BayMedica, a wholly owned subsidiary of InMed. In his new role, Griffin will manage the commercialization of BayMedica’s health and wellness business including existing products as well as the launch of new products. Griffin brings a rich background to this position, having a proven track record as a veteran sales executive. He has served in several senior positions in Fortune 500 companies, including most recently as VP of sales…

Continue Reading

FridayFeb 11, 2022 10:40 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Host CBD and the Global Market Webinar

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, has announced that it will hold a webinar today, Feb.11, at 1:00 p.m. ET. The CBD and the Global Market webinar will be the first of the company’s “State of Play” series. During the webinar, Flora CEO Luis Merchan will explore the opportunities and challenges that lie ahead for the CBD industry in North America, Latin America and the EU. Interested parties should visit https://cnw.fm/tSRGL and, upon registration, can submit questions in advance of the event. To view the full press release, visit https://cnw.fm/LqF2l About Flora Growth…

Continue Reading

ThursdayFeb 10, 2022 1:01 pm

CannabisNewsBreaks – O’Cannabiz International Event Returns to Toronto in June

The O’Cannabiz International Awards, Conference and Expo presented by ND Supplies is heading back to Toronto this year; the three-day event is scheduled for June 1–3, 2022. The event has built a reputation for providing a high-level lineup of exhibitors, speakers and conference topics designed to cover innovative and informative research and the latest in technology. The event also offers invaluable networking opportunities that enable conference participants to rub shoulders with cannabis industry professionals and experts from around the world. This year’s event will also feature new core elements with educational programming delivered on three separate stages. Topics covered will…

Continue Reading

ThursdayFeb 10, 2022 12:21 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Notice of Allowance by USPTO for Smart Medical Inhaler System

RYAH Group (CSE: RYAH) today announced that the U.S. Patent and Trademark Office (the “USPTO”) has issued a Notice of Allowance for U.S. patent application number 15/924,172, filed in respect of the company's IoT-powered, Smart Medical Inhaler system by its wholly owned subsidiary, Potbotics Inc. The hybrid conduction and convection RYAH Smart Medical Inhaler was recently granted Medical Device Certification under ISO 13485:2016/MDSAP and EN ISO 13485:2016 standards for both its hardware and software. “Receiving this Notice of Allowance by the USPTO on our Smart Medical Inhaler is the result of dedication and great effort by all of our product…

Continue Reading

WednesdayFeb 09, 2022 12:43 pm

CannabisNewsBreaks – VPR Brands LP (VPRB) Unveils New Dissim Sport and Dissim Slim Lighters to ‘Best Focus Group’ for Pre-Launch Reaction

VPR Brands (OTC: VPRB) recently debuted its new Dissim Sport and Dissim Slim Line Lighters at the 2022 TPE Tobacco Plus Expo, held in Las Vegas from Jan. 26-28, 2022, and the Champs Trade Show on Feb. 2-5, 2022, at the Las Vegas Convention Center. According to the update, the Slim and Sport line within the Dissim family of lighters will launch with an opening price point between $8-$28 MSRP respectively and are expected to bring a new audience and open new distribution channels. “I personally attended TPE this year so I could interact with the distributors firsthand and gauge…

Continue Reading

TuesdayFeb 08, 2022 2:59 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Reaches ‘Major Milestone,’ Closes on Acquisition

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, through its wholly owned subsidiary RWB Michigan LLC, has closed on the acquisition of PharmaCo Inc. The acquisition, which was originally announced in 2020, brings an extensive list of assets to RWBYF, including 21 medical and adult-use cannabis licenses, eight fully operating dispensaries with five dually licensed, two operational indoor cultivation facilities totaling more than 30,000 square feet, one municipally licensed 10-acre outdoor cultivation facility ready for the 2022 season, two ready-to-open dispensaries, and22 owned properties for potential additional cultivation and dispensary locations.…

Continue Reading

TuesdayFeb 08, 2022 10:43 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces New Chief Strategy Officer

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Vessel founder and CEO James Chose as its new chief strategy officer. Choe brings impressive experience to his new role, with exposure to almost every major industry and a consulting business that has worked with more than 100 brands to launch more than 400 products. In particular, his time spent consulting for leading brands, cannabis producers and Fortune 500 companies has prepared Choe to serve as chief strategy office, where he will work on developing three core pillars: people, design, and community.…

Continue Reading

WednesdayFeb 02, 2022 2:20 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Significant Findings from Sildenafil Animal Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reported positive findings in its recent animal study. The study was designed to evaluate LEXX’s proprietary DehydraTECH(TM) processing of the phosphodiesterase inhibitor ("PDE5 inhibitor") sildenafil for potential use in the management of erectile dysfunction. According to the company, the DehydraTECHsildenafil delivered 74% more drug at four minutes than the concentration-matched, generic control formulation with faster and higher overall delivery of sildenafil into the bloodstream evidenced over the course of the study. The most recognizable sildenafil product available currently is Viagra(R), but some users find it slow to act. Lexaria hopes…

Continue Reading

WednesdayFeb 02, 2022 12:37 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Seeks Approval to Study Patent-Pending Cannabinoid-Based Product to Treat COVID-19

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is hoping to begin research on its patent-pending, cannabinoid-based product. The company is requesting approval from INVIMA, the Colombian FDA, noting that recent studies indicate the potential for cannabinoids to display viral inhibition. FLGC’s research division, Flora Pharma, has filed a USPTO provisional patent application regarding the company’s cannabinoid-based formula, and the company is hoping to take the product through clinical trials under an emergency use authorization (“EUA”) from INVIMA.According to the company, the intent of the study is to identify safe and efficacious…

Continue Reading

FridayJan 28, 2022 11:12 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces Closing of Embark Acquisition

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an innovative health and wellness beverages and products company, has closed on its acquisition of Embark Health Inc., solventless cannabis extraction and delivery technology provider. According to the company, the acquisition will be a significant driver of growth for BevCanna, accelerating its already strong upward trajectory. Embark owns a unique range of brands across all three cannabis 2.0 categories, meaning that BevCanna will now be able to sell differentiated and complementary adult-use and wellness products. In addition, Embark brings a British-Columbia-based, state-of-the-art production facility with $17 million  in tangible and intangible assets to…

Continue Reading